Enhancing the biological properties of zinc complexes with bis(indolyl)methane groups: Synthesis, characterization, DNA interaction, and biocide activity-Reference-Cited by-同舟云学术

Enhancing the biological properties of zinc complexes with bis(indolyl)methane groups: Synthesis, characterization, DNA interaction, and biocide activity

Published:2022-11 Issue: Volume:236 Page:111973
ISSN:0162-0134
Container-title:Journal of Inorganic Biochemistry
language:en
Short-container-title:Journal of Inorganic Biochemistry

Author:

Tessaro Patrícia S.,do Nascimento Tomaz Michele,Farias Giliandro,de Paula Carla P.,Rocha Marina C.,Malavazi Iran,Cunha Anderson,Pimenta Beatriz F.,Terenzi Hernan F.,Mendes Samuel R.,Gariani Rogério A.,Xavier Fernando R.

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Biochemistry

Reference94 articles.

1. Metals in medicine: An overview;Basu;Sci. Rev. Chem. Commun.,2015

2. TPEN, a specific Zn2+ chelator, inhibits sodium dithionite and glucose deprivation (SDGD)-induced neuronal death by modulating apoptosis, glutamate signaling, and voltage-gated K+ and Na+ channels;Zhang;Cell. Mol. Neurobiol.,2017

3. In vitro apoptotic effect of zinc(II) complex with N-donor heterocyclic ligand on breast cancer cells;Eskiler;Turk. J. Biochem.,2019

4. Non-classical anticancer agents: synthesis and biological evaluation of zinc(II) heteroleptic complexes;Liguori;Dalt. Trans.,2010

5. Two zinc(II) and nickel(II)-based complexes: anti breast cancer activity;Cui;Zeitschrift Fur Anorg. Und Allg. Chemie.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiparasitic activity, DNA/BSA binding interaction, molecular docking and DFT studies of mesogenic l-leucine based Schiff base and its derivatize Cu(II) and Zn(II) complexes;Journal of Molecular Structure;2024-05

2. Synthesis of Zn(ii) coordination complexes, their molecular design and docking with SARS-CoV-2 RBD protein and Omicron spike protein;New Journal of Chemistry;2024

3. Synthesis and anticancer mechanisms of zinc(ii)-8-hydroxyquinoline complexes with 1,10-phenanthroline ancillary ligands;Dalton Transactions;2023